Urielle

Urielle is a pioneering adhesive smart catheter patch designed for non-invasive female urine collection, targeting bedridden and mobility- or cognitively-impaired women. This sterile, single-use device addresses the urgent challenge of catheter-associated urinary tract infections (CAUTIs), a leading cause of morbidity, extended hospital stays, and soaring healthcare costs. Traditional indwelling catheters pose infection risks and patient discomfort. Urielle offers an elegant alternative through its multi-layered, hypoallergenic design combining a skin-friendly adhesive, absorbent foam, micro-channeled collector, and breathable barrier film. Operating without power or suction, it ensures secure, flexible fixation that adapts to body movements, preserving dignity and comfort in any posture. Pre-clinical data suggest Urielle may reduce CAUTI incidence by roughly 50%, potentially cutting infection-related complications and antibiotic overuse that fuel antimicrobial resistance. It supports infection prevention, moisture control, odor reduction, and caregiver ease, enhancing patient well-being. Urielle is advancing through the EU MDR Class IIa regulatory pathway and US FDA Class I 510(k)-exempt registration. Planned clinical trials in German geriatric wards will validate safety, leakage, and efficacy, supporting national reimbursement via Germany’s health insurance system (GKV). This strategic focus leverages Germany’s mature medtech ecosystem and fast-growing external catheter market. Urielle is led by experts in medical device innovation and regulation, merging deep technical and clinical insight. It stands at the forefront of female-focused urinary care, poised to transform outcomes, reduce healthcare burdens, and uphold patient dignity. Contact: Ronen Yogev | RY@urielle.eu | +972 544 578877